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Abstract
Background: Studies show that most patients with advanced cancer prefer to die at home. However, not all have
equal chances and the evidence is unclear on whether dying at home is better. This study aims to determine the
association between place of death, health services used, and pain, feeling at peace, and grief intensity.
Methods: Mortality follow-back study of 352 cancer patients who died in hospital (n = 177) or at home (n = 175) in
London, UK. Bereaved relatives identified from death registrations completed a questionnaire including validated
measures of patient’s pain and peace in the last week of life and their own grief intensity. We determined factors
influencing death at home, and associations between place of death and pain, peace, and grief.
Results: Where people died was, for most (80 %), the place where they lived during their last week of life. Four factors
explained >91 % of home deaths: patient’s preference, relative’s preference, home palliative care, or district/community
nursing. The propensity of death at home also increased when the relative was aware of incurability and the patient
discussed his/her preferences with family. Dying in hospital was associated with more hospital days, fewer general
practitioner (GP) home visits, and fewer days taken off work by relatives. Adjusting for confounders, patients who died
at home experienced similar pain levels but more peace in their last week of life (ordered log odds ratio 0.69, P = 0.007).
Grief was less intense for their relatives than for those of patients who died in hospital (β, –0.15 around time of death
and –0.14 at questionnaire completion, P = 0.02).
Conclusion: The study suggests that dying at home is better than hospital for peace and grief, but requires a
discussion of preferences, GP home visits, and relatives to be given time off work.
Trial registration: National Institute of Health Research (NIHR) Clinical Research Network Portfolio. UKCRN7041.
Keywords: Bereavement, Health care surveys, Home care services, Neoplasms, Pain, Palliative care
Background
Studies of patients with advanced cancer and the general
public show that most people would prefer to die at
home [1, 2]. In the UK, the US, and Canada, more ap-
pear to be realising this wish [3–5]. In Japan, Germany,
Greece, and Portugal a trend towards institutionalised
dying persists [6–9]. Despite differing trends, the most
frequent location of death for those dying from cancer is
hospital, with marked variations in the odds of home
death depending on illness-related, individual, and
environmental factors [10–12]. Furthermore, the most
important aim towards the end of life is to ensure the
best possible palliative outcomes. Population ageing and
larger numbers of people dying from cancer represent a
demographic imperative for healthcare systems to ensure
a dignified death for all [13, 14].
There is some evidence showing better results on
psychological, social, and holistic measures of well-being
in the last weeks or days of life for patients dying at
home compared to hospital [15]. However, findings on
symptoms and family outcomes are inconsistent, par-
ticularly for two widely researched outcomes: pain and
grief [16–19]. Tang [20] found that pain was more likely
for patients who died at home (compared to hospital),
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while Escobar Pinzon et al. [21] found the opposite (even
when accounting for confounders) and Jordhoy et al.
[22] found no difference. Addington-Hall and Karlsen,
in the Regional Study of Care for the Dying (RSCD) in
the UK [18], reported higher levels of grief among rela-
tives of patients who died at home (compared to else-
where), while Wright et al. [19], in the Coping with
Cancer study in the US, found that relatives of patients
who died in hospital were more likely to develop pro-
longed grief disorder. Ringdal et al. [23], however, in a
randomised controlled trial of home palliative care, ob-
served no difference by place of death. In an earlier
study in London, Parkes [16] had reported worse symp-
tom control for patients who died at home as opposed
to hospital.
In order to meet patient preference at no expense of
the best possible outcomes, it is crucial to find out
whether death at home is better for patients and fam-
ilies. This study aimed to determine the association be-
tween place of death, health services used, and pain,
feeling at peace, and grief intensity. We first identified
factors influencing the propensity of dying at home
rather than in hospital, and then compared the three
outcomes (pain, peace, and grief ).
Methods
Design, setting, and sample
QUALYCARE is a case-control study that used a mortal-
ity follow-back postal survey methodology of bereaved
relatives (UKCRN7041; protocol in [24]). This is a well-
established method internationally and recommended by
the UK National End of Life Care Strategy in 2008 [25].
It was deemed appropriate for this study given the large
sample size required and the need to examine common
time periods before death for all in the sample.
The study took place in four health districts in London
covering 1.3 million residents. An ecological analysis of
cancer home death rates and socioeconomic deprivation
levels informed the choice of districts to capture vari-
ation (Additional file 1).
Participants were identified from death registrations
and approached by the Office for National Statistics
(ONS). These were persons that registered the death of
people aged ≥18 years who died from cancer (ICD-10
codes C00-D48) during a 1-year period (March 5, 2009,
to March 4, 2010) having lived in the study districts.
Patients were excluded if a coroner registered the death,
since coroners would not be able to provide sufficient
information about the patient’s care and outcomes.
The eligible sample included all who died at home and
a random sample of 150 who died in a National Health
System non-psychiatric hospital in each district (or all
when the eligible number was <150, which happened in
the two smaller districts). Cases comprised persons who
died at home and controls were persons who died in
hospital. A sample of 350 patients was chosen to detect
a minimum standardised difference of 0.30 (power 80 %,
significance 0.05) and allow regression analyses with a
maximum of 35 variables entered and 19 retained, fol-
lowing Altman’s recommendations (n/10 variables and
square root of sample size, respectively) [26].
Potential participants were contacted in writing by the
ONS on behalf of the research team 4–10 months after
registering the patient’s death, and asked to complete a
structured postal questionnaire. Up to two reminders were
sent to people who did not respond at 2 and 4 weeks after
the initial posting; the second reminder included another
copy of the questionnaire. In addition, pseudo-anonymised
death registration data were provided by the ONS.
Case ascertainment
Information on place of death is systematically recorded
in death registration files, as reported by the informant
(i.e. person who registers the death) within 5 days after
the death occurred. We validated this information against
questionnaire data. There were only two disagreements
(Additional file 2). We also asked the respondents how
long the patient had been in the place where they died.
Measurement of factors and outcomes associated with
home death
Our approach to measuring factors and outcomes asso-
ciated with home death was guided by systematic re-
views, a theoretical model of home death in cancer [11],
and findings from the pilot preceding the study [27].
Additional files 3 and 4 include details of the factors and
outcomes analysed; the information was collected in the
same manner for cases and controls. We used validated
specific health outcome measures: Palliative care Outcome
Scale (POS) items to measure pain interference or affect
on the patient (item ranging 0–4, higher scores meaning
more pain interference) and the overall grade of peace dur-
ing the last week of life (ranging 0–5, higher scores mean-
ing more frequent feeling at peace) [28, 29]; and the Texas
Revised Inventory of Grief (TRIG) to measure the respon-
dent’s own grief intensity around time of death (TRIG I;
reported retrospectively; scale ranging 8–40, higher scores
meaning greater grief intensity) and at questionnaire
completion (TRIG II; scale ranging from 13–65) [30].
Cronbach’s alpha estimates were 0.86 (TRIG I) and 0.93
(TRIG II) in the study. According to Bland and Altman
[31], this demonstrates good internal consistency for
comparing groups (α values of 0.70 to 0.80 are regarded as
satisfactory for this purpose).
Approvals and ethics
A National Health System research ethics committee
(REC), the London – Dulwich REC, formerly King’s
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College London REC, approved the study (ref: 09/
H0808/85). Together with the invitation letter and ques-
tionnaire, potential participants were mailed the study
information sheet, a reply slip to decline participation,
and a bereavement information leaflet. Return of a com-
pleted questionnaire was taken as informed consent. We
followed piloted procedures for dealing with queries and
distress [32] and checked returned questionnaires for
participants requiring follow-up action (particularly an-
swers to grief-related questions). If concerns arose and
participants had agreed to be contacted, they were in-
formed about local sources of support [24]. A data access




We developed a multivariate model of factors associated
with home death in two stages. Firstly, direct logistic re-
gression tested a baseline model with nine variables cov-
ering all groups of factors proposed in the theoretical
model: illness related, individual, and environmental
(Additional file 5) [24]. Secondly, one-by-one, we added
detail on cancer type and other variables associated with
home death with P <0.250 in bivariate analysis, retaining
those that stayed significant (P <0.050). Independent var-
iables with near-zero cells and multicollinearity that
cause quasi-separation of the dependent variable lead to
mathematical problems in logistic regression rendering
instability to models [33], and were therefore excluded.
Variables with >10 % missing data were also excluded.
A sub-group analysis tested the final model only for
patients who preferred to die at home. This aimed to
help clinicians make decisions when caring for patients
they know wish to die at home.
Finally, a sensitivity analysis examined the impact of
non-response on the association of home death with five
variables (available through death registrations for par-
ticipants and non-participants): patient’s gender and age,
country of birth, cancer type, and deprivation (measured
using the Index of Multiple Deprivation 2010, in quin-
tiles referring to the area of last residence of the de-
ceased; more details in the footnote of Table 1 [34].
Outcomes
Multivariate ordinal regression (for pain and peace; non-
normally distributed) and linear regression (for grief )
determined associations with place of death. Potential
confounders were entered and retained if significant
(P <0.050), alongside factors associated with home
death in our final model.
The models included the variable district to control
for any design effect due to stratified sampling.
When >10 % of individuals were excluded from the
model due to missing data, χ2 tests identified any
differential by place of death. Analyses were con-
ducted in SPSS for Windows (version 19.0).
Results
Response rates and sample characteristics
We sampled 881 patients; 366 constituted cases and 515
were controls in the case–control study (flowchart in
Additional file 6). Related to this sample, 352 bereaved
relatives (40.0 %) completed the questionnaire. They
were contacted a median of 232 days after the patient
died, i.e. 7 months (interquartile range (IQR), 189–
280 days), with no significant difference between
cases and controls.
Patients died at a median age of 76 years (IQR, 67–83)
and 55 % were men (Table 1). The two most common
cancer groups were digestive (35 % of men, 23 % of
women) and respiratory or intra-thoracic (21 % of men,
25 % of women). Most of the proxy respondents (66 %)
were women and 90 % were first line relatives of the
patient (i.e. spouses, partners, offspring, siblings, or
parents). Their median age was 59 years (IQR, 49–70).
Home death was preferred by >66 % of patients in both
groups and 92 % of relatives of patients who died at
home, but only by 32 % of relatives of patients who died
in hospital, with <17 % of relatives in both groups chan-
ging their mind in the patient’s last 3 months of life.
For most decedents (80 %), where they died was also
where they lived during their last week of life (Fig. 1). Of
those who died in hospital, 28 % were admitted in the
last week of life, 51 % in the last month but prior to the
last week, and 21 % >1 month before they died. Of those
who died at home, 45 % had not been admitted for the
whole of their last 6 months of life and 11 % had gone
home in their last week.
Factors associated with dying at home rather than
in hospital
Figure 2 summarises the associations contrasting bivari-
ate and multivariate results. The first model includes un-
adjusted associations found through bivariate analysis
(Additional file 7) and the second model includes ad-
justed but also the strongest unadjusted associations that
due to near-zero cell frequencies and multicollinearity
could not be included in multivariate logistic regression.
Four inter-related factors explained >91 % of home
deaths and >67 % of hospital deaths: preference for
home death by the patient, preference for home death
by the patient’s relative, receipt of home palliative care
in the last 3 months of life, receipt of district/community
nursing in the last 3 months of life. In addition, patients
who died in hospital were less likely to have had Marie
Curie nursing (these nurses care for people at home in
the last few months or weeks of their lives, with the core
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Table 1 Sample characteristics
All Home death Hospital death
(n = 352) (n = 175) (n = 177)
Patient’s gender
Male 192 (54.5 %) 94 (53.7 %) 98 (55.4 %)
Female 160 (45.5 %) 81 (46.3 %) 79 (44.6 %)
Patient’s age
Median in years (IQR) 76 (67–83) 76 (66–83) 76 (67–83.5)
Type of cancer (underlying cause of death)
Digestive 105 (29.8 %) 59 (33.7 %) 46 (26.0 %)
Respiratory and intra-thoracic organs 80 (22.7 %) 40 (22.9 %) 40 (22.6 %)
Eye, brain, and other parts of the central nervous system 13 (3.7 %) 11 (6.3 %) 2 (1.1 %)
Breast 18 (5.1 %) 9 (5.1 %) 9 (5.1 %)
Lymphoid, haematopoietic, and related tissue 26 (7.4 %) 8 (4.6 %) 18 (10.2 %)
Genitourinary 67 (19.0 %) 25 (14.3 %) 42 (23.7 %)
Unspecified and other 43 (12.2 %) 23 (13.1 %) 20 (11.3 %)
Mobility at 3 months to death (EQ-5D)
No problems 95 (28.4 %) 42 (25.6 %) 53 (31.0 %)
Some problems 211 (63.0 %) 106 (64.6 %) 105 (61.4 %)
Confined to bed 29 (8.7 %) 16 (9.8 %) 13 (7.6 %)
Self-care at 3 months to death (EQ-5D)
No problems 148 (44.7 %) 68 (42.2 %) 80 (47.1 %)
Some problems 128 (38.7 %) 68 (42.2 %) 60 (35.3 %)
Unable to wash/dress her/himself 55 (16.6 %) 25 (15.5 %) 30 (17.6 %)
Usual activities at 3 months to death (EQ-5D)
No problems 76 (22.8 %) 31 (18.8 %) 45 (26.6 %)
Some problems 152 (45.5 %) 82 (49.7 %) 70 (41.4 %)
Unable to perform usual activities 106 (31.7 %) 52 (31.5 %) 54 (32.0 %)
Patient’s country of birth
UK/Ireland 288 (81.8 %) 142 (81.1 %) 146 (82.5 %)
Elsewhere 64 (18.2 %) 33 (18.9 %) 31 (17.5 %)
Patient’s ethnicity
White British/Irish 291 (84.6 %) 145 (84.8 %) 146 (84.4 %)
White other/unspecified 21 (6.1 %) 13 (7.6 %) 8 (4.6 %)
Other 32 (9.3 %) 13 (7.6 %) 19 (11.0 %)
IMD 2010 (patient’s residence area) a
5th quintile (least deprived) 89 (25.3 %) 46 (26.3 %) 43 (24.3 %)
4th quintile 69 (19.6 %) 41 (23.4 %) 28 (15.8 %)
3rd quintile 55 (15.6 %) 31 (17.7 %) 24 (13.6 %)
2nd quintile 85 (24.1 %) 35 (20.0 %) 50 (28.2 %)
1st quintile (most deprived) 54 (15.3 %) 22 (12.6 %) 32 (18.1 %)
Patient’s marital status
Married/with partner 199 (58.0 %) 117 (68.8 %) 82 (47.4 %)
Widowed 86 (25.1 %) 34 (20.0 %) 52 (30.1 %)
Divorced/separated 25 (7.3 %) 9 (5.3 %) 16 (9.2 %)
Never married 33 (9.6 %) 10 (5.9 %) 23 (13.3 %)
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Table 1 Sample characteristics (Continued)
Patient’s living with relatives
Yes 249 (71.6 %) 145 (83.8 %) 104 (59.4 %)
No 99 (28.4 %) 28 (16.2 %) 71 (40.6 %)
Patient’s preference for PoD
Home 262 (83.7 %) 168 (97.7 %) 94 (66.7 %)
Other or no preference 51 (16.3 %) 4 (2.3 %) 47 (33.3 %)
Relative’s gender
Male 118 (33.8 %) 53 (30.6 %) 65 (36.9 %)
Female 231 (66.2 %) 120 (69.4 %) 111 (63.1 %)
Relative’s age
Median in years (IQR) 59 (49–70) 60 (50–71) 57 (49–68)
Relative’s relationship to patient
Spouse/partner 147 (41.9 %) 85 (48.6 %) 62 (35.2 %)
Son/daughter 142 (40.5 %) 75 (42.9 %) 67 (38.1 %)
Brother/sister 20 (5.7 %) 4 (2.3 %) 16 (9.1 %)
Other 42 (12.0 %) 11 (6.3 %) 31 (17.6 %)
Relative’s preference for PoD at 3 months to death
Home 215 (61.8 %) 159 (91.9 %) 56 (32.0 %)
Other or no preference 133 (38.2 %) 14 (8.1 %) 119 (68.0 %)
Change in relative’s preference for PoD in 3 months prior death
Yes 42 (12.7 %) 16 (9.5 %) 26 (16.0 %)
No 289 (87.3 %) 153 (90.5 %) 136 (84.0 %)
a Index of Multiple Deprivation (IMD) 2010 national quintile of the area of last residence of the deceased. This information was provided by the Office for National
Statistics based on death registration information of the patient’s lower layer super output area of residence (LSOA). The IMD 2010 score is a measure based on 38
indicators, chosen to cover a broad range of economic, social, and housing issues, into a single relative deprivation score for each LSOA in England [34]. The
different domains are combined using appropriate weights to calculate the IMD 2010 score, an overall measure of multiple deprivation experienced by people
living in the respective area. This represents unmet needs caused by lack of resources of all kinds (income, employment, health and disability, education skills and
training, barriers to housing and other services, crime and living environment)
Percentages may not add to 100 % due to rounding
IQR, Interquartile range; PoD, Place of death
Fig. 1 Permanence in place versus timing of last transition by place of death. The figure shows how long the patients were in the place where
they died. Numbers and percentages by place of death are placed backwards from death according to the time period when the last transition
happened. For example, 75 out of 168 people who died at home (45 %) were at home for 6 months or more (with no transition). Two (1 %)
went home in their last 24 hours of life. Eleven patients had missing data: seven home deaths, four hospital deaths (including two people who
gave inconsistent information).
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Fig. 2 Unadjusted and adjusted associations with death at home. a Factors identified through bivariate analysis (P <0.05); b Factors retained in the
final multivariate model (P <0.05) except for those in italic, which show the strongest unadjusted associations but due to near-zero cell frequencies
and multicollinearity with place of death could not be included in the logistic regression model
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service being one-to-one overnight nursing; 4 % in the
hospital group compared to 41 % in the home group).
Only seven patients who received care from Marie Curie
nurses died in hospital. Three other variables had >10 %
missing data and were therefore excluded from further
analysis (whether the patient discussed their preference
for place of death with professionals, whether the pa-
tient’s preference for place of death differed from the
relative’s preference, and whether there had been a key
professional point of contact in the 3 months before
death).
Figure 3 presents the relative influence of five factors
in multivariate analysis. Two originated from the base-
line model: hospital days and general practitioner (GP)
home visits. Three represent new factors: length of rela-
tive’s awareness of incurability, discussion of patient’s
preference for place of death with family, and relative’s
work arrangements in the last 3 months before the pa-
tient died. All five associations were statistically signifi-
cant (P ≤0.001), although there was a differential in missing
data, with more information missing in the hospital group
than in the home group (31 % and 20 %, P = 0.023).
A gradient was evident in the relationships of home
death with hospital days and GP home visits (Fig. 3).
When patients stayed 15–28 days in hospital during the
last 3 months of life, the odds of dying at home were
75 % lower compared to patients with 0–7 days in hos-
pital (adjusted odds ratio (AOR), 0.25; 0.10–0.61). Fur-
thermore, the odds decreased by 91 % for patients who
were in hospital for more than 28 days in the last
3 months of life (AOR, 0.09; 0.03–0.25). Patients who re-
ceived three or more GP home visits during their last
3 months of life had six times greater odds of dying at
home compared to patients with just one or no GP
home visits (AOR, 6.27; 2.83–13.91). Those with two
visits also had greater odds of dying at home (AOR,
3.42; 1.23–9.55). Home death odds were higher when
relatives knew of incurability >1 week before death
(AOR, 6.51; 2.84–14.91), when patients discussed their
preferences with family (AOR, 3.39; 1.63–7.04), and if rel-
atives took >14 days off work in the last 3 months before
the patient died (AOR, 9.94; 2.56–38.65 versus <4 days
off) or were not working (AOR, 3.70; 1.28–10.68).
Sub-group and sensitivity analyses
Testing the five-factor model on patients who preferred
to die at home (i.e. excluding 38 patients who preferred
to die elsewhere and 13 who had no preference), all fac-
tors remained significant except for whether the patient
discussed their preference for place of death with family.
Sensitivity analysis examining the impact of non-response
on the results showed no differences on the influence that
the five factors available for this analysis had on home
death (patient’s gender, age, cancer type, country of birth,
and deprivation; analyses in Additional files 8 and 9).
Differences in pain, peace, and grief by place of death
The results for pain and peace were maintained in
adjusted analyses (Table 2). Based on respondents’ ac-
counts, we found that the level of pain experienced by
patients in their last week of life was no different for
those who died at home than for those who died in
hospital (median 1 (slightly, IQR, 0–2) compared to
2 (moderately, 0–2) in POS item ranging 0–4; M-W
Fig. 3 Five factors independently associated with death at home rather than in hospital. Factors retained in the final multivariate model (P <0.050). The
dots present adjusted odds ratios and horizontal lines indicate 95 % confidence intervals. The model was statistically reliable [Hosmer and Lemeshow
χ2(8,263) = 4.721, P= 0.787]; it correctly classified 82 % of the cases (persons who died at home) and 79 % of the controls (persons who died in hospital)
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(335) = 15.456, z = 1.671, P = 0.095). Regardless of se-
verity level, the prevalence of pain was 61.9 % among
patients who died at home and 70.1 % among pa-
tients who died in hospital. Moderate to overwhelm-
ing pain was experienced by 53.3 % of patients in
the hospital group as opposed to 44.0 % of those in
the home group.
Patients who died at home were reported to feel more
frequently at peace during their last week of life than pa-
tients who died in hospital (median 4 (most of the time,
IQR, 3–5) compared to 3 (some of the time, 1.5–4) in
POS item ranging 0–5, M-W(330) = 9.809, z = –4.546,
P <0.001). A minority (11.8 % of patients who died
at home and 24.8 % of those who died in hospital)
were not very often or not at all at peace in their
last week of life.
The grief intensity experienced by the respondents
around time of death and at questionnaire completion
(median of 7 months after the patient died) was similar in
the home and hospital groups (mean, 20.52 (SD, 7.91) and
20.78 (8.25), respectively, in TRIG I scale ranging 8–40,
t-test(318) = –0.281, P = 0.779; mean, 45.02 (11.26) and
43.11 (14.10), respectively, in TRIG II scale ranging 13–65,
t-test(299) = 1.327, P = 0.185). However, once confounders
were taken into account (stronger grief reactions were as-
sociated with spouses/partners, presence at time of death,
family discussion of preferences for place of death and
relative’s time off work in the last 3 months before
the patient died), the levels of grief were less intense
when the patient died at home compared to hospital,
both at the time of death (β –0.15, P = 0.020) and ques-
tionnaire completion (β –0.14, P = 0.023; Table 3).
Table 2 Multivariate ordinal regressions of factors associated with pain and peace
Unadjusted Adjusted
n Median score (IQR) Ordered log OR
(95 % CI)
P value n Ordered log OR
(95 % CI)
P value
Pain in last week of life (POS item)
Place of death
Hospital 167 2 (0–2) Ref. 166 Ref.
Home 168 1 (0–1) −0.33 (–0.72 to 0.06) 0.094 168 −0.25 (–0.65 to 0.15) 0.228
Relative’s relationship to the patient
Spouse/partner 139 1 (0–2) Ref. 139 Ref.
Son/daughter 135 1 (0–2) 0.39 (–0.04 to 0.82) 0.076 135 0.38 (–0.05 to 0.80) 0.087
Brother/sister 20 2 (1–2.5) 1.03 (0.19 to 1.88) 0.017 20 0.94 (0.08 to 1.80) 0.031
Other 40 1 (0–2) 0.47 (–0.17 to 1.10) 0.148 40 0.38 (–0.26 to 1.03) 0.245
Peace in last week of life (POS item)
Place of death
Hospital 161 3 (1.5–4) Ref. 140 Ref.
Home 169 4 (3–5) 0.93 (0.52 to 1.33) <0.001 160 0.69 (0.19 to 1.19) 0.007
Relative’s relationship to the patient
Spouse/partner 136 4 (3–4) Ref. 124 Ref.
Son/daughter 137 4 (3–4) −0.14 (–0.57 to 0.29) 0.510 126 −0.16 (–0.62 to 0.30) 0.489
Brother/sister 15 3 (2–4) −0.85 (–1.80 to 0.10) 0.080 12 −0.88 (–1.95 to 0.20) 0.112
Other 41 3 (1.5–4) −0.75 (–1.38 to –0.12) 0.019 38 −0.51 (–1.17 to 0.16) 0.138
Length of relative’s awareness of incurability
Never or aware for less than one week 76 3 (1–4) Ref. 73 Ref.
Aware for one week or more 237 4 (3–4) 0.65 (0.18 to 1.12) 0.006 227 0.69 (0.19 to 1.18) 0.389
Patient’s preference for place of death discussed
with family
No 122 4 (2–4) Ref. 115 Ref.
Yes 193 4 (3–4) 0.79 (0.38 to 1.21) <0.001 185 0.64 (0.17 to 1.11) 0.008
POS items were used to measure pain interference or affect on the patient (0–4 scale, higher scores meaning more pain interference) and the overall grade of
peace (0–5 scale, higher scores meaning more frequent feeling at peace) during the last week of life [28, 29]. The model on pain included 334 patients (94.9 %),
with 167:1 patients per variable. Model statistics: Pearson χ2(24) = 19.281, P = 0.737; Nagelkerke R2 = 0.030. The model on peace included 300 patients (85.2 %),
with 75:1 patients per variable. Model statistics: Pearson χ2(119) = 121.466, P = 0.420; Nagelkerke R2 = 0.121
CI, Confidence interval; OR, Odds ratio; POS, Palliative care Outcome Scale
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Table 3 Multivariate linear regressions of factors associated with grief
Unadjusted Adjusted
n M (SD) B (95 % CI) β P value B (95 % CI) β P value sr2
Grief intensity around time of death (TRIG
I)
Place of death
Hospital 158 20.78 (8.25) Ref. Ref.
Home 162 20.52 (7.91) −0.25 (–2.03 to 1.52) −0.02 0.779 −2.44 (–4.50 to –0.39) −0.15 0.020 0.02
Relative’s relationship to the patient
Spouse/partner 130 21.85 (8.16) Ref. Ref.
Son/daughter 134 20.25 (7.58) −1.61 (–3.55 to 0.33) −0.10 0.104 −1.89 (–3.86 to 0.08) −0.12 0.060 0.01
Brother/sister 15 17.87 (6.32) −3.99 (–8.29 to 0.31) −0.11 0.069 −4.83 (–9.09 to –0.56) −0.13 0.027 0.02
Other 40 19.45 (9.40) −2.40 (–5.25 to 0.45) −0.10 0.098 −3.16 (–6.14 to –0.19) −0.13 0.037 0.01
Relative’s presence at time of death
No 94 19.04 (8.51) Ref. Ref.
Yes 225 21.24 (7.72) 2.19 (0.27 to 4.12) 0.13 0.026 2.41 (0.28 to 4.54) 0.14 0.027 0.02
Patient’s preference for place of death
discussed with family
No 121 19.00 (8.01) Ref. Ref.
Yes 188 21.57 (8.06) 2.57 (0.73 to 4.42) 0.16 0.006 3.01 (1.11 to 5.03) 0.19 0.002 0.03
Grief intensity at time of questionnaire
completion (TRIG II)
Place of death
Hospital 158 43.11 (14.10) Ref. Ref.
Home 158 45.02 (11.26) 1.91 (–0.92 to 4.73) 0.08 0.185 −3.63 (–6.76 to –0.50) −0.14 0.023 0.01
Relative’s relationship to the patient
Spouse/partner 126 49.21 (10.00) Ref. Ref.
Son/daughter 133 41.92 (11.71) −7.55 (–9.85 to –5.26) −0.29 <0.001 −6.69 (–9.98 to –3.40) −0.26 <0.001 0.04
Brother/sister 15 40.67 (16.17) −10.93 (–15.75 to –6.21) −0.19 <0.001 −6.78 (–13.45 to –0.11) −0.11 0.046 0.02
Other 41 36.98 (16.18) −11.92 (–15.22 to –8.63) −0.31 <0.001 −12.54 (–17.09 to –7.99) −0.32 <0.001 0.08
Relative’s presence at time of death
No 90 38.77 (15.29) Ref. Ref.
Yes 225 46.11 (10.94) 6.58 (4.36 to 8.81) 0.25 <0.001 4.77 (1.51 to 8.04) 0.17 0.004 0.01
Relative’s work arrangements in last three
months of patient’s life
0 to 3 days off work 58 37.50 (13.52) Ref. Ref.
4 to 14 days off work 44 45.14 (11.92) 7.64 (2.88 to 12.40) 0.22 0.002 7.07 (2.41 to 11.73) 0.20 0.003 0.02
15+ days off work 47 50.32 (9.19) 12.82 (8.15 to 17.49) 0.37 <0.001 8.44 (3.64 to 13.23) 0.24 0.001 0.03
Not working 144 44.97 (12.37) 7.47 (3.77 to 11.18) 0.30 <0.001 3.87 (3.64 to 13.23) 0.15 0.048 0.01
Patient’s preference for place of death
discussed with family
No 123 41.83 (13.86) Ref. Ref.
Yes 182 45.34 (11.96) 2.80 (0.52 to 5.09) 0.11 0.016 2.88 (0.07 to 5.82) 0.11 0.056 0.01
The TRIG was used to measure grief intensity for the respondent; the first scale asks respondents about their experience at the time of death (TRIG I 8–40 scale, 8 items,
measured retrospectively) and the second scale asks about their experience at the time of questionnaire completion (TRIG II 13–65 scale, 13 items; higher scores meaning
greater grief intensity; [30]). TRIG I model included 307 bereaved relatives (87.2 %), with more missing amongst hospital deaths than amongst home deaths (16.4 % vs.
9.1 %, P = 0.042). Model statistics: R for regression significantly different than zero, F(9,297) = 4.492, P <0.001; R2 = 0.120, adjusted R2 = 0.093. TRIG II model included
281 bereaved relatives (79.8 %), with no significant differences in the proportion missing amongst hospital deaths and home deaths (22.6 % vs. 17.7 %,
P = 0.254). Model statistics: R for regression significantly different than zero, F(12,268) = 8.181, P <0.001; R2 = 0.268, adjusted R2 = 0.235
CI, Confidence interval; B, Unstandardised regression coefficient; β, Standardised regression coefficient; M, mean; sr2, Semipartial correlation; SD, Standard deviation; TRIG,
Texas Revised Inventory of Grief
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Discussion
To date, QUALYCARE is the most comprehensive
population-based study of factors and outcomes associ-
ated with dying at home compared to hospital; it in-
cludes over 350 people who died from cancer and their
relatives in the largest metropolitan area in the UK. The
study fills in a critical gap in providing new evidence
suggesting that dying at home is better than hospital for
peace and grief, with no difference in the pain level ex-
perienced in the last week of life.
Limitations
There are limitations related to the study design, meas-
urement, and analysis. The study is retrospective, and
hence we show associations which do not necessarily in-
dicate causality. It was conducted in London, therefore
the transferability of findings to other regions where
home care services (including palliative care) are less
available, for example, is uncertain. The response rate
was low (40 %), although it falls within the range of
similar population-based postal surveys with bereaved
relatives in the UK [35–37] and also compares to
service-based surveys in the UK and Canada [38, 39].
Through sensitivity analysis, we identified no impact of
non-response on the association of five variables with
home death, although we were only able to examine a
limited number of variables (those available for partici-
pants and non-participants).
The measurement of factors and outcomes was sys-
tematic and standardised but some variables (subjective
factors, pain, peace) are vulnerable to recall and observer
bias from respondents. Some studies suggest that rela-
tives either overestimate or polarize their ratings of
patient’s pain 4–7 months after death compared to pro-
spective reports [40, 41]. Our data do not show a
polarization, but we cannot confirm whether the levels
of pain, for example, were overestimated (this would re-
quire prospective data on the same patients). Even so,
the pain prevalence found (61.9 % among patients who
died at home, 70.1 % among patients who died in
hospital) was comparable to the pooled estimate of 64 %
(95 % CI, 58–69 %) reported in a meta-analysis of ad-
vanced cancer patients, which excluded proxy data [42].
In contrast, it was lower than the weighted mean
pain prevalence recently reported by Higginson et al.
(76.1 % and 73.9 % including and excluding proxy
data, respectively) [43]. These comparisons suggest
that if there was overestimation, the magnitude of an
effect on findings is likely to be small. The use of a
postal method (which offers protection against social
desirability) and the high salience of the events in
question (circumstances surrounding the patient’s death)
might have increased recall accuracy in both cases and
controls.
Factors associated with dying at home
We found several modifiable factors associated with
place of death that are amenable to intervention and are
rarely measured. Namely, we identified four conditions
that are almost essential for patients to die at home ra-
ther than in hospital: patient’s preference, relative’s pref-
erence, receipt of home palliative care, and of district
nursing/community nursing. The study also shows that,
if patients get intensive nursing care specific to the end
of life (provided by Marie Curie nurses), they very rarely
die in hospital. However, 96 % of those who died in hos-
pital did not get such help. The study observes dose-
response relationships for two factors from a previous
model [11]: hospital days and GP home visits. It chal-
lenges current thinking about the influence of patient’s
functional status, social conditions, and living arrange-
ments, showing no association once other factors are
considered. Importantly, we identified three factors
previously overlooked – length of relative’s awareness of
incurability, discussion of patient’s preference with fam-
ily, and relative’s work arrangements in the 3 months be-
fore death. Our final model explained well why some
patients died at home whilst others died in hospital.
Subject to testing, this may be effective for clinical
decision-making.
Preferences for place of death
Given the importance of meeting people’s preferences
for place of death and preferences being one of the most
influential factors on actual place of death, it is meaning-
ful that home was reported as the preferred location of
death for more than two thirds of patients in both
groups. However, it should be noted that not all wish to
die at home and that there are situations in which dying
at home may not be feasible. Moreover, a home death
was preferred by 92 % of relatives of patients who died
at home, but only by 32 % of relatives of patients who
died in hospital. Adding to findings from a systematic
review of preferences for dying at home [1], we found a
lower home preference from relatives compared to
patients; this stresses the crucial role of families in
caring for patients at home and in decision-making
processes [1, 44]. Most relatives said that their own pref-
erences were stable in the last 3 months before death, with
less than a fifth in both groups (cases and controls) chan-
ging their mind during this period. Early conversations
about preferences involving patients and families seem,
therefore, appropriate, provided they are well-conducted
and preferences are monitored over time.
Differences in outcomes between dying at home and
in hospital
Our findings suggest that, in addition to increasing choice, a
home death is associated with similar experiences (in terms
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of pain) and sometimes better experiences and outcomes
(in terms of peace and grief) for people dying of cancer
and for their relatives. The study helps elucidate previous
contradictory evidence on pain and grief, and provides
some of the first evidence on sense of peace in relation to
place of death.
Pain
The absence of a statistically significant difference in the
levels of pain experienced by patients who died at home
and by those who died in hospital concurs with some
studies [22, 45] and disagree with others [16, 21]. Our
findings differ from a seminal study conducted by Parkes
in London (1967–1971) [16], where among a sample of
165 patients, he found significantly greater pain at home
than in hospital. However, Parkes included in the home
group people who were at home for most of the time
but were admitted to hospital in their last week of life.
As it is possible that admission could be due to prob-
lems controlling pain, the inclusion of this sub-group in
home deaths (18/65 of the home group) may have
shaped the results.
It is indeed plausible that some patients who died in
hospital were admitted because of more severe problems
controlling pain at home, while those who stayed at
home might have experienced fewer complications in
the last week of life. It is also plausible that relatives
were more aware of pain when people were at home,
hence our findings on pain must be regarded with care.
However, it is of relevance that, in QUALYCARE, the
median level of pain was lower in the home group than
in the hospital group, though the difference did not
reach statistical significance. Interestingly, one recent
study that shares the design, measurement, and time-
frame with QUALYCARE (the EPACS study in
Germany) found that patients who died at home were
less likely to have experienced pain (57.8 % vs. 67.9 %)
than patients who died in hospital [21].
Peace
Few studies have examined whether patients’ sense of
peace differs by place of death. Our findings support
those from a small observational study in Philadelphia
[46], where more bereaved relatives of patients who died
at home thought these had been at peace than relatives
of patients who died elsewhere (16/18 and 5/10, re-
spectively, P = 0.003). In contrast, in the South West of
the Netherlands, van der Heide et al. [45] found no dif-
ferences in physicians’ perspectives on whether the pa-
tient died peacefully between those who died at home
and elsewhere (29/42 and 28/41, respectively, P = 0.94).
However, this finding is limited to the degree the physi-
cians were involved and present in the last days of life
(which was unknown).
The one point difference in median peace scores be-
tween the home and hospital groups (4, i.e. most of the
time, compared to 3, i.e. some of the time, measured
through the POS peace item with a 0–5 range) is of clin-
ical significance. However, both medians were higher
(i.e. better) than the threshold recommended by Selman
et al. [47] as indicative of distress in the POS peace item,
i.e. scores of 0–1. Applying this threshold, the differ-
ences are still evident: 11.8 % of patients who died at
home and 24.8 % of those who died in hospital were
on or below the recommended threshold, indicating
distress.
It is possible that this difference reflects the import-
ance of some of the dimensions that Selman et al. [47]
identified in the concept of peace with patients. These
include being aware and accepting death, but also rela-
tional aspects such as the ability to be at home with
family. However, the association of home death with in-
creased peace persisted when adjusted for relative’s
awareness of incurability, family discussion of prefer-
ences for place of death, and respondent’s relationship to
the patient. The finding of differences in peace but not
in pain suggests the former may encompass but tran-
scends the latter. Other aspects may play a role, for ex-
ample, those related to the environment in hospitals
(noisy and busy settings) and the patient’s consciousness
level (e.g. being asleep may be regarded by the relatives
as being peaceful).
Grief
Our findings showing less intense grief for relatives in
the home group refute previous UK population-based
data from the 1990’s [18]. RSCD investigators found that
bereaved relatives of patients who died at home had
higher levels of psychological distress around 10 months
after the patient died as measured by the GHQ-28
(mean score 24.7 compared to 22.2, P <0.01) and were
more likely to say they missed the deceased a great deal,
and less likely to say that they had come to terms with
the death, that they looked forward to things as usual, or
that things were going reasonably well for them by then.
The results on the two latter aspects were similar in the
sub-group of spouses, whilst differences in the former
two lost significance in this sub-group. No adjustments
were made to the results, though, and this is important
because relatives of patients who die at home are more
likely to be spouses, but also more likely be present at
the time of death, factors we found were associated with
greater grief intensity. Adjusting for these confounders
is, therefore, important.
In addition, the RSCD compared psychological distress
and three items measuring cognitive and emotional
aspects of grief. However, grief encompasses other
important facets (e.g. behavioural, relational) [48]. In
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QUALYCARE, we measured the whole construct of
grief, using a validated measure with high Cronbach’s
alphas, demonstrating good internal consistency for the
purpose of comparing groups [32]. However, it is more
plausible that adjustments rather than measurement issues
explain the differences between our results and the RSCD. It
is also likely that home support increased over time (from
1990 to 2010), which may impact on grief adjustment.
Our findings concur with the Coping with Cancer
study conducted more recently in the US [19], which
showed that relatives of patients who died in hospital
were at heightened risk of prolonged grief disorder
(assessed using a validated scale) compared to relatives
of patients who died at home with hospice care (AOR,
8.83; 95 % CI, 1.51–51.77). An important finding from
the Coping with Cancer study was that none of the
psychological variables measured at baseline (median
4.5 months before the patient died) were associated with
place of death, which suggests pre-bereavement psycho-
logical morbidity may not confound the effect of place of
death on post-bereavement complications. QUALYCARE
results on grief also align with the Cambridge Hospital at
Home randomised controlled trial in the UK [49].
Implications for clinical practice
It is clear from the findings that most people dying of
cancer prefer to die at home and that this wish is often
supported by family, yet seldom met. Those that do die
at home (in regions of London) appear to spend their
last days in greater peace, nearly always with family
around them, and with pain controlled to a similar level
to those who die in hospital. Based on the data, nearly
two fifths of the people who die of cancer at home in
the regions in the study can expect a pain-free death.
Around another fifth are affected only slightly – this
makes over half of all home deaths in cancer. Such en-
couraging reality reflects multiple factors, which include
the work of clinicians on the ground, particularly of
those working in the community, to ensure that patients
and families are adequately supported at home. Yet, the
findings highlight the need to do more. There are some
people for whom death at home is not peaceful and
pain-free, and there are relatives that are left in intense
grieving. Input from home palliative care services,
district/community nurses, and GPs is essential, but
not enough to guarantee to a patient with advanced
cancer who wants to die at home that they will achieve
their wish. Other factors in our model (Figs. 2 and 3)
require attention from all clinicians involved in cancer
care in terms of risk assessment and care management.
Conclusions
QUALYCARE presents novel knowledge suggesting that
dying at home is better than hospital for peace and grief,
and it also shows what needs to be in place for advanced
cancer patients to die at home if they wish. Examining
the variations associated with home death in cancer in a
comprehensive way revealed that dying at home is a
complex yet tangible goal, one that can be achieved in
comfortable conditions. The findings indicate that mak-
ing this a reality for more patients with incurable cancer
requires a wide response: from oncologists to check the
identified risk factors and discuss preferences with pa-
tients and families, from GPs to be proactive and make
home visits, and from policymakers to implement com-
prehensive home care packages and develop measures to
sustain family involvement in care. Failure to do this
may contribute to crises and subsequent admissions,
leading to an undesired death in hospital, less peaceful
than can be achieved at home and more difficult for
relatives to live with.
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